Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 18%
Buy 29%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is positioned for long-term success with its diverse portfolio, strategic investments in AI and digital solutions, and strong leadership. Their recent acquisition of Intelerad is expected to drive profits and they have set a goal of 60% recurring revenues to ensure stability and growth. While they face competition and sustainability risks, their focus on responsible practices and ability to innovate new products will help mitigate these challenges.

Bears say

GE HealthCare Techs is projected to experience significant sales growth in late 2026 and beyond, driven by competition in the market for their MRI systems and investments in new products and M&A. However, they face intense competition from established companies and potential challenges such as trade wars and inflation that could affect their performance. Additionally, while their use of AI technology and focus on sustainability and human capital are positives, their expansion into the theranostics field and implementation of AI for maternal and neonatal care may face regulatory hurdles.

GEHC has been analyzed by 17 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 29% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 17 analysts, GEHC has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.